Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387014881> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4387014881 endingPage "AB51" @default.
- W4387014881 startingPage "AB51" @default.
- W4387014881 abstract "Scalp involvement is common in patients with psoriasis, is often associated with itch, and significantly impacts quality of life [1,2]. The Phase III VOYAGE 2 trial compared guselkumab, an interleukin-23(p19) inhibitor, with placebo and with adalimumab in patients with moderate-to-severe plaque psoriasis [3]. This post hoc analysis explored scalp responses during guselkumab treatment and withdrawal in patients with scalp involvement (as indicated at screening) who were randomised to guselkumab 100 mg at Week (W)0 and W4, then every 8 weeks. At W28, Psoriasis Area and Severity Index (PASI) 90 responders were re-randomised to continue (n=159) or discontinue (n=164) guselkumab; non-responders continued guselkumab (n=84). Among guselkumab responders remaining on treatment, mean scalp-specific Investigator Global Assessment (ss-IGA) score rapidly declined from 2.9 at W0 to 0.2 at W24, and 0.3 at W48; mean PASI head scores were 2.0, 0.1 and 0.1, respectively, and were consistent with total PASI score improvements (21.9, 0.6 and 1.0, respectively). Changes in ss-IGA and PASI scores were less marked in non-responders than responders, but also showed improvements. Guselkumab responders who had treatment withdrawn showed an increase in mean ss-IGA score from 0.2 (W24) to 1.3 (W48) and mean PASI head score (0.1 to 0.6, respectively). Changes in mean Psoriasis Symptoms and Signs Diary itch scores and Dermatology Life Quality Index scores paralleled changes in mean ss-IGA scores for all cohorts. Guselkumab demonstrated rapid and durable clinical efficacy, itch relief and quality-of-life improvements in patients with scalp psoriasis. Further investigation is required to understand predictors of scalp response." @default.
- W4387014881 created "2023-09-26" @default.
- W4387014881 creator A5026402548 @default.
- W4387014881 creator A5056126124 @default.
- W4387014881 creator A5074786702 @default.
- W4387014881 creator A5075890647 @default.
- W4387014881 creator A5082952206 @default.
- W4387014881 creator A5087989437 @default.
- W4387014881 creator A5091798251 @default.
- W4387014881 date "2023-09-01" @default.
- W4387014881 modified "2023-10-09" @default.
- W4387014881 title "43840 Guselkumab in patients with scalp psoriasis: A post hoc analysis of the VOYAGE 2 trial" @default.
- W4387014881 doi "https://doi.org/10.1016/j.jaad.2023.07.209" @default.
- W4387014881 hasPublicationYear "2023" @default.
- W4387014881 type Work @default.
- W4387014881 citedByCount "0" @default.
- W4387014881 crossrefType "journal-article" @default.
- W4387014881 hasAuthorship W4387014881A5026402548 @default.
- W4387014881 hasAuthorship W4387014881A5056126124 @default.
- W4387014881 hasAuthorship W4387014881A5074786702 @default.
- W4387014881 hasAuthorship W4387014881A5075890647 @default.
- W4387014881 hasAuthorship W4387014881A5082952206 @default.
- W4387014881 hasAuthorship W4387014881A5087989437 @default.
- W4387014881 hasAuthorship W4387014881A5091798251 @default.
- W4387014881 hasConcept C126322002 @default.
- W4387014881 hasConcept C16005928 @default.
- W4387014881 hasConcept C2776173921 @default.
- W4387014881 hasConcept C2778515351 @default.
- W4387014881 hasConcept C2780564577 @default.
- W4387014881 hasConcept C67761136 @default.
- W4387014881 hasConcept C71924100 @default.
- W4387014881 hasConceptScore W4387014881C126322002 @default.
- W4387014881 hasConceptScore W4387014881C16005928 @default.
- W4387014881 hasConceptScore W4387014881C2776173921 @default.
- W4387014881 hasConceptScore W4387014881C2778515351 @default.
- W4387014881 hasConceptScore W4387014881C2780564577 @default.
- W4387014881 hasConceptScore W4387014881C67761136 @default.
- W4387014881 hasConceptScore W4387014881C71924100 @default.
- W4387014881 hasIssue "3" @default.
- W4387014881 hasLocation W43870148811 @default.
- W4387014881 hasOpenAccess W4387014881 @default.
- W4387014881 hasPrimaryLocation W43870148811 @default.
- W4387014881 hasRelatedWork W1203010501 @default.
- W4387014881 hasRelatedWork W1947735615 @default.
- W4387014881 hasRelatedWork W2048992728 @default.
- W4387014881 hasRelatedWork W2049961763 @default.
- W4387014881 hasRelatedWork W2559285362 @default.
- W4387014881 hasRelatedWork W2887758007 @default.
- W4387014881 hasRelatedWork W2894901650 @default.
- W4387014881 hasRelatedWork W2897398813 @default.
- W4387014881 hasRelatedWork W4226239662 @default.
- W4387014881 hasRelatedWork W4290322881 @default.
- W4387014881 hasVolume "89" @default.
- W4387014881 isParatext "false" @default.
- W4387014881 isRetracted "false" @default.
- W4387014881 workType "article" @default.